Mounjaro 10mg Injection: Reaching This Stage of Your Treatment

Step 1: How you reach the 10mg injection

Tirzepatide treatment does not begin at 10mg. The licensed schedule, set out in the Mounjaro SmPC on the eMC, starts at 2.5mg, a dose designed to let your system adjust, not to deliver full therapeutic effect. If you tolerated the 2.5mg starting dose well, your prescriber moves you to 5mg after four weeks, then to 7.5mg, and then to 10mg, each step separated by roughly a month. That means arriving at 10mg typically takes around twelve to sixteen weeks from your first pen.

The pace is deliberate. Slower titration keeps gastrointestinal side effects manageable and gives the prescriber checkpoints to assess how your body is responding. Jumping ahead is not something a patient can or should self-manage. If you want to understand the full dose ladder before you start, the Mounjaro dose guide sets out what each step involves.

At each repeat, a prescriber reviews whether the increase is appropriate. Patients transferring from another provider are asked to supply evidence of their current dose before any increase is confirmed, that applies at 10mg as much as anywhere else.

Step 2: What the 10mg pen actually looks like and how it works

The 10mg Mounjaro arrives as a pre-filled KwikPen, the same format used at every strength, with each pen holding four doses, one per week for a month. The mechanism is the same throughout the schedule: tirzepatide activates both GIP and GLP-1 receptors, the two gut-hormone pathways involved in appetite signalling and blood-sugar regulation. It also slows gastric emptying, which is a large part of why many people feel fuller for longer. Mounjaro is the only dual-agonist weight-management medicine licensed in the UK, as the NHS tirzepatide page explains.

When a pen is dispatched through a regulated UK pharmacy, it is sent refrigerated and tracked. Through nume (through nume) orders placed before 12pm on a working day are reviewed the same day and, once approved, sent out with DPD; you receive a tracking number and the pen arrives the next working day in plain, unbranded packaging. The pen itself is ready to use: no mixing, no preparation beyond letting it reach room temperature per the Patient Information Leaflet.

Injection sites rotate between abdomen, thigh and upper arm. Storage details (including the limited window the pen can spend outside a fridge) are in the leaflet that comes with every pen; rely on that, not on memory.

Step 3: Tolerability at 10mg and what to watch for

By the time most people reach 10mg, the worst of the early nausea has passed. That said, a dose increase can bring a short-lived return of gastrointestinal symptoms: nausea, loose stools, constipation, reflux or indigestion. These typically ease within a week or two as the body adjusts. Fatigue, headache and mild dizziness have also been reported at this stage.

There are symptoms that warrant prompt medical attention rather than watchful waiting. Severe, persistent stomach pain (especially if it spreads toward the back, with or without vomiting) should be assessed urgently, as this can indicate pancreatitis. The MHRA highlighted acute pancreatitis as a known serious risk for GLP-1 medicines in its January 2026 Drug Safety Update; the Yellow Card scheme allows patients to report any suspected side effect directly to the regulator. Any suspected allergic reaction, or symptoms of dehydration following severe vomiting or diarrhoea, also need medical attention without delay.

Women taking oral contraceptives should be aware that tirzepatide's effect on gastric emptying may reduce pill absorption; adding a non-oral method for the first four weeks at each new dose is the standard advice. Discuss this with your prescriber if it applies to you.

Step 4: Whether 10mg is your maintenance dose or a stepping stone

Some people find 10mg is the right long-term dose for them, effective, well tolerated, and where their prescriber chooses to stay. Others progress to the previous rung or eventually to an earlier one if side effects require stepping back, and others continue upward toward 12.5mg or 15mg. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed that higher doses produced greater average weight reduction (around 20–21% at 15mg over 72 weeks) but a person's optimal dose depends on their response and tolerance, not on the headline trial figure. The prescriber's job is to find the highest dose that works for you without causing undue side effects.

The general cost landscape for Mounjaro across doses is covered in detail on the Mounjaro cost page. Eligibility to continue, and what the clinical picture looks like at six months, is something our prescribers discuss as part of every review.

If you are not yet on Mounjaro and want to understand whether treatment might be appropriate for your situation, a free consultation with a GPhC-registered prescriber is the right starting point. Speak to our prescribers, there is no commitment, and the review happens the same day.